⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 22, 2022New England Journal of MedicineOpen Access

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy

Malini B. DeSilva Jacob L. Haapala Gabriela Vazquez‐Benitez Kimberly K. Vesco Matthew F. Daley Darios Getahun Ousseny Zerbo Allison L. Naleway Jennifer C. Nelson Joshua T.B. Williams Simon J. Hambidge Thomas G. Boyce Candace C. Fuller Heather S. Lipkind Eric Weintraub Michael M. McNeil Elyse O. Kharbanda

View Full Paper

Ask AI

Bookmark

Share

Abstract

Evaluation of Acute Adverse Events after Covid-19Vaccination during Pregnancy 1 to 7 days after vaccination Fever Malaise

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

DeSilva et al. (2022) studied this question.

synapsesocial.com/papers/6a6eb2cc2163a0a01bc34d8e https://doi.org/10.1056/nejmc2205276

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020Risk Assessment · 2020 · 1,065 citations
2Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020Risk Assessment · 2020 · 1,207 citations
3Expanding the Evidence and Indications for Thrombectomy in Ischemic StrokeNew England Journal of Medicine · Fri,
4Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic StrokeNew England Journal of Medicine · Fri,
5Trial of Endovascular Therapy for Mild Stroke with Large-Vessel OcclusionNew England Journal of Medicine · Fri,

More from New England Journal of Medicine

Interim Analysis of a Phase 3 Trial of Povetacicept in IgA NephropathyFri,
Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 TrialFri,
Atacicept in IgA Nephropathy — Phase 3 Trial Final Efficacy AnalysisThu,
Sibeprenlimab in IgA Nephropathy — Final Phase 3 Trial AnalysisThu,
Examining the Use of Race in Clinical AlgorithmsWed,